{"id":67608,"date":"2021-01-13T23:02:00","date_gmt":"2021-01-13T15:02:00","guid":{"rendered":"https:\/\/www.chinapulse.com\/?p=159813"},"modified":"2021-01-13T23:02:00","modified_gmt":"2021-01-13T15:02:00","slug":"chinese-covid-19-vaccine-far-less-effective-than-initially-claimed-in-brazil-sparking-concerns","status":"publish","type":"post","link":"https:\/\/www.chinalegalblog.com\/en\/2021\/01\/13\/chinese-covid-19-vaccine-far-less-effective-than-initially-claimed-in-brazil-sparking-concerns\/","title":{"rendered":"Chinese COVID-19 vaccine far less effective than initially claimed in Brazil, sparking concerns"},"content":{"rendered":"<p>January 13, 2021<\/p>\n<p>A leading Chinese COVID-19 vaccine developed by Sinovac Biotech was just 50.38% effective in late-stage trials in Brazil, significantly lower than earlier results showed, according to a statement published by the government of Sao Paulo Tuesday.<\/p>\n<p>While the number exceeds the threshold required for regulatory approval, it falls far below the 78% previously announced , raising questions as to the veracity of the data and fueling skepticism over the apparent lack of transparency regarding Chinese vaccines .&#8230;<\/p>\n<p>The post <a rel=\"nofollow\" href=\"https:\/\/www.chinapulse.com\/data-news\/2021\/01\/13\/chinese-covid-19-vaccine-far-less-effective-than-initially-claimed-in-brazil-sparking-concerns\/\">Chinese COVID-19 vaccine far less effective than initially claimed in Brazil, sparking concerns<\/a> appeared first on <a rel=\"nofollow\" href=\"https:\/\/www.chinapulse.com\/\">ChinaPulse.com<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>January 13, 2021<br \/>\nA leading Chinese COVID-19 vaccine developed by Sinovac Biotech was just 50.38% effective in late-stage trials in Brazil, significantly lower than earlier results showed, according to a statement published by the government of Sao Paul&#8230;<\/p>\n","protected":false},"author":250,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[144,213,325,339,288,194,249,1542,334,296],"tags":[7582,2636,3472,10323,10324,2214,10400,5941,7035,2972],"class_list":["post-67608","post","type-post","status-publish","format-standard","hentry","category-china","category-china-news","category-education","category-hong-kong","category-medicine","category-news-chinese-law","category-russia","category-technology","category-university","category-world-health-organization","tag-biotech","tag-brazil","tag-chinese","tag-coronavirus","tag-covid-19","tag-indonesia","tag-turkey","tag-united-arab-emirates","tag-vaccine","tag-xi-jinping"],"_links":{"self":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/67608","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/users\/250"}],"replies":[{"embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/comments?post=67608"}],"version-history":[{"count":1,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/67608\/revisions"}],"predecessor-version":[{"id":67609,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/67608\/revisions\/67609"}],"wp:attachment":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/media?parent=67608"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/categories?post=67608"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/tags?post=67608"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}